Haemonetics (NYSE: HAE) announced that it received FDA approval for its NexSys PCS plasma collection system with Persona PLUS ...

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 47th Annual Institutional Investors ...

BOSTON, Nov. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2026, which ended September 27, 2025, are available on the ...

The London Company, an investment management company, released “The London Company Small Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities ...

Haemonetics Corporation (NYSE:HAE) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Haemonetics ...

BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...

Detailed price information for Haemonetics Corp (HAE-N) from The Globe and Mail including charting and trades.

BOSTON, Jan. 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, ...

(RTTNews) - Haemonetics Corp. (HAE) reported third-quarter adjusted profit per share of $0.84 compared to $0.81, prior year. On average, eight analysts polled by Thomson Reuters expected the company ...

Haemonetics received clearance from the Food and Drug Administration for its next-generation plasma collection system. The medical technology company said Monday that the FDA granted 510(k) clearance ...